Incidence of influenza virus infections in children in Hong Kong in a 3-year randomized placebo-controlled vaccine study, 2009-2012

Clinical Infectious Diseases

Volumn 59, Issue 4, 2014, Pages 517-524

  Cowling, Benjamin J ^a   Perera, Ranawaka A P M ^a   Fang, Vicky J ^a   Chan, Kwok Hung ^a   Wai, Winnie ^a   So, Hau Chi ^a   Chu, Daniel K W ^a   Wong, Jessica Y ^a   Shiu, Eunice Y ^a   Ng, Sophia ^b   Ip, Dennis K M ^a   Peiris, J S Malik ^a   Leung, Gabriel M ^a  

^a UNIVERSITY OF HONG KONG   (Hong Kong)

^b PRINCETON UNIVERSITY   (United States)

Author keywords

Immunity; Incidence rates; Influenza virus; Vaccination

Indexed keywords

INFLUENZA VACCINE; PLACEBO; INACTIVATED VACCINE;

ADOLESCENT; ANTIBODY TITER; ARTICLE; CHILD; CHILDHOOD DISEASE; CONTROLLED STUDY; EPIDEMIC; FEMALE; FOLLOW UP; HONG KONG; HONG KONG INFLUENZA; HUMAN; INCIDENCE; INFECTION PREVENTION; INFLUENZA A (H1N1); INFLUENZA A (H3N2); INFLUENZA B; INFLUENZA VACCINATION; INFLUENZA VIRUS A H1N1; INFLUENZA VIRUS A H3N2; MAJOR CLINICAL STUDY; MALE; PANDEMIC INFLUENZA; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SEASONAL INFLUENZA; SINGLE DRUG DOSE; THROAT CULTURE; TREATMENT DURATION; CLINICAL TRIAL; IMMUNOLOGY; INFLUENZA, HUMAN; ORTHOMYXOVIRUS; TREATMENT OUTCOME;

ADOLESCENT; CHILD; FEMALE; HONG KONG; HUMANS; INCIDENCE; INFLUENZA VACCINES; INFLUENZA, HUMAN; MALE; ORTHOMYXOVIRIDAE; PLACEBOS; TREATMENT OUTCOME; VACCINES, INACTIVATED;

EID: 84905057156     PISSN: 10584838     EISSN: 15376591     Source Type: Journal    
DOI: 10.1093/cid/ciu356     Document Type: Article

References (36)

1. Cauchemez S, Valleron AJ, Boelle PY, Flahault A, Ferguson NM. Estimating the impact of school closure on influenza transmission from Sentinel data. Nature 2008; 452: 750-4.
2. Baguelin M, Flasche S, Camacho A, Demiris N, Miller E, Edmunds WJ. Assessing optimal target populations for influenza vaccination programmes: an evidence synthesis and modelling study. PLoS Med 2013; 10:e1001527.
3. Monto AS, Davenport FM, Napier JA, Francis T Jr. Effect of vaccination of a school-age population upon the course of an A2-Hong Kong influenza epidemic. Bull World Health Organ 1969; 41: 537-42.
4. Hurwitz ES, Haber M, Chang A, et al. Effectiveness of influenza vaccination of day care children in reducing influenza-related morbidity among household contacts. JAMA 2000; 284: 1677-82.
5. Esposito S, Marchisio P, Cavagna R, et al. Effectiveness of influenza vaccination of children with recurrent respiratory tract infections in reducing respiratory-related morbidity within the households. Vaccine 2003; 21: 3162-8.
6. Piedra PA, Gaglani MJ, Kozinetz CA, et al. Herd immunity in adults against influenza-related illnesses with use of the trivalent-live attenuated influenza vaccine (CAIV-T) in children. Vaccine 2005; 23: 1540-8.
7. Loeb M, Russell ML, Moss L, et al. Effect of influenza vaccination of children on infection rates in Hutterite communities: a randomized trial. JAMA 2010; 303: 943-50.
8. Cowling BJ, Ng S, Ma ES, et al. Protective efficacy of seasonal influenza vaccination against seasonal and pandemic influenza virus infection during 2009 in Hong Kong. Clin Infect Dis 2010; 51: 1370-9.
9. Longini IM Jr, Halloran ME. Strategy for distribution of influenza vaccine to high-risk groups and children. Am J Epidemiol 2005; 161: 303-6.
10. Bansal S, Pourbohloul B, Meyers LA. A comparative analysis of influenza vaccination programs. PLoS Med 2006; 3:e387.
11. Cowling BJ, Ng S, Ma ES, et al. Protective efficacy against pandemic influenza of seasonal influenza vaccination in children in Hong Kong: a randomized controlled trial. Clin Infect Dis 2012; 55: 695-702.
12. Cowling BJ, Chan KH, Fang VJ, et al. Comparative epidemiology of pandemic and seasonal influenza A in households. N Engl J Med 2010; 362: 2175-84.
13. Wong JY, Wu P, Nishiura H, et al. Infection fatality risk of the pandemic A(H1N1)2009 virus in Hong Kong. Am J Epidemiol 2013; 177: 834-40.
14. Cowling BJ, Chan KH, Fang VJ, et al. Facemasks and hand hygiene to prevent influenza transmission in households: a randomized trial. Ann Intern Med 2009; 151: 437-46.
15. Molenberghs G, Kenward MG. Missing data in clinical studies. Hoboken, NJ: John Wiley & Sons, 2007.
16. Petrie JG, Ohmit SE, Johnson E, Cross RT, Monto AS. Efficacy studies of influenza vaccines: effect of end points used and characteristics of vaccine failures. J Infect Dis 2011; 203: 1309-15.
17. Wu JT, Ma ES, Lee CK, et al. The infection attack rate and severity of 2009 pandemic H1N1 influenza in Hong Kong. Clin Infect Dis 2010; 51: 1184-91.
18. Riley S, Kwok KO, Wu KM, et al. Epidemiological characteristics of 2009 (H1N1) pandemic influenza based on paired sera from a longitudinal community cohort study. PLoS Med 2011; 8:e1000442.
19. Wu P, Goldstein E, Ho LM, et al. Excess mortality impact of two epidemics of pandemic influenza A(H1N1pdm09) virus in Hong Kong. Influenza Other Respir Viruses 2014; 8: 1-7.
20. Ambrose CS, Wu X. Evidence of homosubtypic but not heterosubtypic immunity in young children following wild-type influenza illness. Pediatr Infect Dis J 2011; 30: 900-1.
21. Hoskins TW, Davies JR, Smith AJ, Allchin A, Miller CL, Pollock TM. Influenza at Christ's Hospital: March, 1974. Lancet 1976; 1: 105-8.
22. Grilli EA, Davies JR, Smith AJ. Infection with influenza A H1N1. 1. Production and persistence of antibody. J Hyg (Lond) 1986; 96: 335-43.
23. Gill PW, Murphy AM. Naturally acquired immunity to influenza type A: a further prospective study. Med J Aust 1977; 2: 761-5.
24. Gill PW, Murphy AM. Naturally acquired immunity to influenza type A. Lessons from two coexisting subtypes. Med J Aust 1985; 142: 94-8.
25. Ferguson NM, Galvani AP, Bush RM. Ecological and immunological determinants of influenza evolution. Nature 2003; 422: 428-33.
26. Slepushkin AN The effect of a previous attack of A1 influenza on susceptibility to A2 virus during the 1957 outbreak. Bull World Health Organ 1959; 20: 297-301.
27. Sonoguchi T, Naito H, Hara M, Takeuchi Y, Fukumi H. Cross-subtype protection in humans during sequential, overlapping, and/or concurrent epidemics caused by H3N2 and H1N1 influenza viruses. J Infect Dis 1985; 151: 81-8.
28. Epstein SL Prior H1N1 influenza infection and susceptibility of Cleveland Family Study participants during the H2N2 pandemic of 1957: an experiment of nature. J Infect Dis 2006; 193: 49-53.
29. Carrat F, Lavenu A. Heterosubtypic immunity to influenza: right hypothesis, wrong comparison. J Infect Dis 2006; 193: 1613; author reply-4.
30. Sullender W, Fowler K, Krishnan A, et al. Design and initiation of a study to assess the direct and indirect effects of influenza vaccine given to children in rural India. Vaccine 2012; 30: 5235-9.
31. Monto AS, Koopman JS, Longini IM Jr Tecumseh study of illness. XIII. Influenza infection and disease, 1976-1981. Am J Epidemiol 1985; 121: 811-22.
32. Fox JP, Cooney MK, Hall CE, Foy HM. Influenzavirus infections in Seattle families, 1975-1979. II. Pattern of infection in invaded households and relation of age and prior antibody to occurrence of infection and related illness. Am J Epidemiol 1982; 116: 228-42.
33. Horby P, Mai le Q, Fox A, et al. The epidemiology of interpandemic and pandemic influenza in Vietnam, 2007-2010: the Ha Nam household cohort study I. Am J Epidemiol 2012; 175: 1062-74.
34. Hayward AC, Fragaszy EB, Bermingham A, et al. Comparative community burden and severity of seasonal and pandemic influenza: results of the Flu Watch cohort study [Epub ahead of print]. Lancet Respir Med 2014. pii: S2213-2600(14)70034-7. doi: 10.1016/S2213-2600(14)70034-7.
35. Horby PW Community studies of influenza: new knowledge, new questions. Lancet Respir Med 2014.
36. Cauchemez S, Horby P, Fox A, et al. Influenza infection rates, measurement errors and the interpretation of paired serology. PLoS Pathog 2012; 8:e1003061.